Best news

HealthDay – (HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:

AP – J&J APOLOGY: The chief executive of Johnson & Johnson plans to tell Congress his company „let the public down” with a string of quality problems that forced it to recall millions of medications in the past year.

Reuters – Researchers have found a gene that may explain why coffee may lower the risk of Parkinson’s disease for some people, and that might explain why some experimental drugs do not appear to be working.

Reuters – Bristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.

AP – Seniors with high drug costs will soon have more options to help them cope with Medicare’s prescription coverage gap.

HealthDay – (HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:

HealthDay – TUESDAY, Sept. 28 (HealthDay News) — Nursing home workers who are routinely exposed to violent encounters with either the residents they care for or visitors to the nursing home face a three times greater risk for developing painful musculoskeletal conditions, new research reveals.

HealthDay – TUESDAY, Sept. 28 (HealthDay News) — In an effort to improve the prognosis of patients battling triple-negative breast cancer, scientists have identified a unique biomarker that may eventually allow some to receive a more targeted treatment.

HealthDay – TUESDAY, Sept. 28 (HealthDay News) — Despite previous findings to the contrary, new research indicates that black patients with non-small cell lung are as likely to harbor a specific mutation in tumors as white patients.

HealthDay – TUESDAY, Sept. 28 (HealthDay News) — A new blood test to spot a cluster of specific proteins may indicate the presence of prostate cancer more accurately and earlier than is now possible, new research suggests.